Lord, Abbett & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-412,677	Closed	-$47M	–	654
2022 Q4	$47M	Sell	412,677 -82,452	-17%	-$6.85M	0.17%	174
2022 Q3	$30.6M	Sell	495,129 -233,856	-32%	-$16.3M	0.11%	246
2022 Q2	$58.1M	Buy	728,985 +253,753	+53%	+$24M	0.21%	136
2022 Q1	$50M	Sell	475,232 -41,776	-8%	-$4.07M	0.13%	222
2021 Q4	$55.7M	Sell	517,008 -276,307	-35%	-$30.1M	0.13%	239
2021 Q3	$86.9M	Buy	793,315 +238,789	+43%	+$24.8M	0.21%	155
2021 Q2	$51.9M	Buy	554,526 +147,351	+36%	+$13.6M	0.13%	249
2021 Q1	$37.5M	Buy	407,175 +368,698	+958%	+$31.1M	0.1%	313
2020 Q4	$2.81M	Buy	38,477 +20,090	+109%	+$1.49M	0.01%	616
2020 Q3	$1.43M	Buy	+18,387	New	+$1.27M	﹤0.01%	610
2015 Q2	–	Sell	-1,124,104	Closed	-$29.2M	–	1016
2015 Q1	$29.2M	Buy	+1,124,104	New	+$20.6M	0.07%	389